Wenling Ye Lihong Cai Minjie Zhang Yali Wu Huina Sun Yan-Dong Wang Yubing Xia
10.3389/fimmu.2023.1221418
Front Immunol
2023 Jul 27;14:1221418.
camrelizumab pd-1 case report immune checkpoint inhibitor primary liver cancer
CC BY
https://pubmed.ncbi.nlm.nih.gov/37575222/
Carcinoma, Hepatocellular / drug therapy Liver Neoplasms / drug therapy
Carcinoma, Hepatocellular / drug therapy Liver Neoplasms / drug therapy Case Reports Research Support, Non-U.S. Gov't Adult Antibodies, Monoclonal, Humanized / therapeutic use Humans Immune Checkpoint Inhibitors Tumor Microenvironment camrelizumab Immune Checkpoint Inhibitors Antibodies, Monoclonal, Humanized
PMC10413100
37575222
Case Report: Successful treatment of advanced hepatocarcinoma with the PD-1 inhibitor Camrelizumab
2023